Ann: MDR Investor presentation - Adheris acquisition & Cap raise, page-11

Research and assumptions continue........

All the major MedAdvisor Welam employees (MDR's US arm) are all ex/current Adheris employees.

https://www.linkedin.com/in/jim-rotsart-0a8b0a9
https://www.linkedin.com/in/keith-kiarsis-a01a3233
https://www.linkedin.com/in/roula-fitzgerald-3070a321

John Ciccio only rejoined Adheris as President in late 2019 and will run the combined Adheris and MedAdvisor US business.

Seems like a coup from the inside. These guys would know the business intimately.

US markets up 8% in the last week.

Tech stocks also trending up and set for further gains.
https://www.ft.com/content/dd354faa-5fca-4e0a-8fa2-4386462bc0c7

Comparing M7T which has had a stellar run, their FY20 report showed $18M revenue and a $220M MC.

I see no reason why MedAdvisor won't be able to secure another US$27M from Adheris under their stewardship.

With the Top 20 being full of Management and insiders I also can't see any rejections in voting for Syneos to convert some of their payments into shares (and held in escrow for 12 months).

Regardless of the big orange baby trying to destabilise democracy, MDR should reopen with a bang.